Likes	Subject	Older
	pincher chart on the daily and weekly, I	Bullish	DavidTrader	03/27/23 1:14 PM
	Hmmm just crickets around here, I don’t mind		Lilman72003	03/22/23 4:17 PM
	NKTR -24%/AH on_termination_of Bempeg program following phase-3 failures		DewDiligence	04/14/22 5:23 PM
	Ouch Ouch		Frankestin	03/14/22 10:36 AM
	NKTR’s Bempeg fails as addend to Opdivo in		DewDiligence	03/14/22 9:57 AM
	NKTR +18% on clinical-trial_collaboration_testing Bempeg+Keytruda in_H&N_cancer:		DewDiligence	02/17/21 10:21 AM
	* * $NKTR Video Chart 01-15-2020 * *		ClayTrader	01/15/20 4:41 PM
	Comments on the JPM webcast: #msg-153299506.		DewDiligence	01/14/20 7:45 PM
	We talk about NKTR a little on #board-1418.		DewDiligence	01/11/20 2:02 PM
	On what board are people discussing Nektar ?		Sluicebox	01/11/20 7:21 AM
	Yea, bloody taa for !? I will check back.		czni	12/14/19 5:36 PM
	Well if that wasn’t the strangest thing on		czni	12/14/19 5:27 PM
	I have been doing a lot of studying		czni	12/14/19 5:11 PM
	You saw that, yes. thanks but I do not		czni	12/14/19 5:04 PM
	That’s why I love this board. You don’t		czni	12/14/19 5:01 PM
	Hey gang, Im a quiet holder but have a		czni	12/14/19 4:53 PM
	Thinking people are just taking profits today?		Clemdane	12/11/19 11:44 AM
	News: $NKTR 2 Stocks That Soared Monday While		whytestocks	12/09/19 10:45 PM
	News: $NKTR Why Nektar Therapeutics Stock Popped Today		whytestocks	12/09/19 7:15 PM
	News: $NKTR Nektar Therapeutics Announces Presentation of New		whytestocks	12/09/19 6:30 PM
	News: $NKTR Nektar Therapeutics Presents Data from First-in-Human		whytestocks	11/10/19 11:15 AM
	News: $NKTR Nektar Therapeutics Presents New Clinical and		whytestocks	11/09/19 6:04 PM
	* * $NKTR Video Chart 10-08-2019 * *		ClayTrader	10/08/19 6:05 PM
	Everything You Need For Your Premarket Including Nektar		behindthebid	08/09/19 8:58 AM
	NKTR says two production lots of NKTR-214 were		DewDiligence	08/08/19 5:20 PM
	Hmm… https://finance.yahoo.com/news/nektar-therapeutics-reports-financial-res		DewDiligence	08/08/19 4:25 PM
	A trial in Germany is testing a neoantigen		jondoeuk	08/06/19 4:54 PM
	News: $NKTR Nektar Therapeutics and Bristol-Myers Squibb Announce		whytestocks	08/01/19 4:50 PM
	NKTR 4Q18 CC transcript:		DewDiligence	03/01/19 9:42 AM
	ASCO-SITC Clinical Immuno-Oncology Symposium abstract		jondoeuk	02/25/19 5:35 PM
	Dr. Zalevsky will provide updates on NKTR-214 during		jondoeuk	12/29/18 3:43 PM
	From this: ''With NKTR-214, a kinetically engineered IL-2		jondoeuk	11/25/18 3:58 PM
	SITC data—Melanoma PIVOT-02 ORR=53%* (20*/38)—24% (9/38) CRs:		DewDiligence	11/09/18 6:46 PM
	I had a few too many. What I		jondoeuk	11/08/18 12:30 PM
	NKTR 3Q18 results—cash=$2.0B:		DewDiligence	11/07/18 6:45 PM
	NKTR 3Q18 results—cash=$353M:		DewDiligence	11/07/18 4:41 PM
	NKTR, PFE ink clinical-trial collaboration for NKTR-214 with		DewDiligence	11/06/18 9:29 AM
	You own ONCS because of management?		DewDiligence	11/03/18 6:42 PM
	$GNCA, $ONCS, $GRTS, $REPL, $DVAX, $ADRO and $IDRA*		jondoeuk	11/03/18 6:25 PM
	Which biotech companies are you long? TIA		DewDiligence	10/27/18 6:40 PM
	Melanoma Bridge Conference: 'Immune monitoring after NKTR-214 plus		jondoeuk	10/27/18 6:14 PM
	Appears that institutions have made up their mind		tigerpac	10/24/18 11:47 AM
	On second thought, #msg-144383492 is a better explanation		DewDiligence	10/22/18 4:01 PM
	My take, FWIW: #msg-144374334.		DewDiligence	10/22/18 11:24 AM
	The shareholder is always the last one to		tigerpac	10/22/18 11:16 AM
	After examining the "rebuttal" text more closely, I'm		DewDiligence	10/04/18 8:30 PM
	If that's a real email response from the		DewDiligence	10/04/18 3:09 PM
	Someone emailed the IR department and posted the		jondoeuk	10/04/18 10:34 AM
	3 different posters on the NKTR YMB "Conversations"		stockbettor	10/04/18 9:22 AM
	Where is that from?		DewDiligence	10/03/18 6:58 PM
Likes	Subject	Older

Older

DavidTrader

03/27/23 1:14 PM

pincher chart on the daily and weekly, I

Lilman72003

03/22/23 4:17 PM

Hmmm just crickets around here, I don’t mind

DewDiligence

04/14/22 5:23 PM

NKTR -24%/AH on_termination_of Bempeg program following phase-3 failures

Frankestin

03/14/22 10:36 AM

Ouch Ouch

DewDiligence

03/14/22 9:57 AM

NKTR’s Bempeg fails as addend to Opdivo in

DewDiligence

02/17/21 10:21 AM

NKTR +18% on clinical-trial_collaboration_testing Bempeg+Keytruda in_H&N_cancer:

ClayTrader

01/15/20 4:41 PM

* * $NKTR Video Chart 01-15-2020 * *

DewDiligence

01/14/20 7:45 PM

Comments on the JPM webcast: #msg-153299506.

DewDiligence

01/11/20 2:02 PM

We talk about NKTR a little on #board-1418.

Sluicebox

01/11/20 7:21 AM

On what board are people discussing Nektar ?

czni

12/14/19 5:36 PM

Yea, bloody taa for !? I will check back.

czni

12/14/19 5:27 PM

Well if that wasn’t the strangest thing on

czni

12/14/19 5:11 PM

I have been doing a lot of studying

czni

12/14/19 5:04 PM

You saw that, yes. thanks but I do not

czni

12/14/19 5:01 PM

That’s why I love this board. You don’t

czni

12/14/19 4:53 PM

Hey gang, Im a quiet holder but have a

Clemdane

12/11/19 11:44 AM

Thinking people are just taking profits today?

whytestocks

12/09/19 10:45 PM

News: $NKTR 2 Stocks That Soared Monday While

whytestocks

12/09/19 7:15 PM

News: $NKTR Why Nektar Therapeutics Stock Popped Today

whytestocks

12/09/19 6:30 PM

News: $NKTR Nektar Therapeutics Announces Presentation of New

whytestocks

11/10/19 11:15 AM

News: $NKTR Nektar Therapeutics Presents Data from First-in-Human

whytestocks

11/09/19 6:04 PM

News: $NKTR Nektar Therapeutics Presents New Clinical and

ClayTrader

10/08/19 6:05 PM

* * $NKTR Video Chart 10-08-2019 * *

behindthebid

08/09/19 8:58 AM

Everything You Need For Your Premarket Including Nektar

DewDiligence

08/08/19 5:20 PM

NKTR says two production lots of NKTR-214 were

DewDiligence

08/08/19 4:25 PM

Hmm… https://finance.yahoo.com/news/nektar-therapeutics-reports-financial-res

jondoeuk

08/06/19 4:54 PM

A trial in Germany is testing a neoantigen

whytestocks

08/01/19 4:50 PM

News: $NKTR Nektar Therapeutics and Bristol-Myers Squibb Announce

DewDiligence

03/01/19 9:42 AM

NKTR 4Q18 CC transcript:

jondoeuk

02/25/19 5:35 PM

ASCO-SITC Clinical Immuno-Oncology Symposium abstract

jondoeuk

12/29/18 3:43 PM

Dr. Zalevsky will provide updates on NKTR-214 during

jondoeuk

11/25/18 3:58 PM

From this: ''With NKTR-214, a kinetically engineered IL-2

DewDiligence

11/09/18 6:46 PM

SITC data—Melanoma PIVOT-02 ORR=53%* (20*/38)—24% (9/38) CRs:

jondoeuk

11/08/18 12:30 PM

I had a few too many. What I

DewDiligence

11/07/18 6:45 PM

NKTR 3Q18 results—cash=$2.0B:

DewDiligence

11/07/18 4:41 PM

NKTR 3Q18 results—cash=$353M:

DewDiligence

11/06/18 9:29 AM

NKTR, PFE ink clinical-trial collaboration for NKTR-214 with

DewDiligence

11/03/18 6:42 PM

You own ONCS because of management?

jondoeuk

11/03/18 6:25 PM

$GNCA*, $ONCS*, $GRTS, $REPL, $DVAX, $ADRO** and $IDRA***

DewDiligence

10/27/18 6:40 PM

Which biotech companies are you long? TIA

jondoeuk

10/27/18 6:14 PM

Melanoma Bridge Conference: 'Immune monitoring after NKTR-214 plus

tigerpac

10/24/18 11:47 AM

Appears that institutions have made up their mind

DewDiligence

10/22/18 4:01 PM

On second thought, #msg-144383492 is a better explanation

DewDiligence

10/22/18 11:24 AM

My take, FWIW: #msg-144374334.

tigerpac

10/22/18 11:16 AM

The shareholder is always the last one to

DewDiligence

10/04/18 8:30 PM

After examining the "rebuttal" text more closely, I'm

DewDiligence

10/04/18 3:09 PM

If that's a real email response from the

jondoeuk

10/04/18 10:34 AM

Someone emailed the IR department and posted the

stockbettor

10/04/18 9:22 AM

3 different posters on the NKTR YMB "Conversations"

DewDiligence

10/03/18 6:58 PM

Where is that from?

Older

Nektar Therapeutics (NKTR)

Followers	34	Posters	55
Posts (Today)	0	Posts (Total)	266
Created	10/20/05	Type	Free
Moderators

http://www.nektar.com

http://finance.yahoo.com/q?s=NKTR

Nektar Therapeutics, a biopharmaceutical company, develops various drug products and product candidates using its proprietary drug delivery technologies. Its technology platforms comprise PEGylation Technology designed to enhance the performance of various drug classes, including macromolecules, small molecules, and other drugs; and Pulmonary Technology, which includes technologies for drug formulation, powder processing, powder filling, and packaging, as well as dry powder inhaler devices and liquid nebulizer devices. The company's technologies are used in 10 approved products; 3 partner programs that have been filed for with the FDA; and 12 development programs in human clinical trials. Its partnered products include Tobramycin inhalation powder, a Phase III clinical product for treating lung infections; NKTR-061, a Phase II clinical product for gram-negative pneumonias; Ciprofloxacin Inhalation Powder, a Phase II clinical product for lung infections; Pulmonary dronabinol, a Phase II product for migraine; and Exubera Inhalation Powder for adult type 1 and type 2 diabetes. The company's partnered product portfolio also comprises Neulasta for neutropenia; PEGASY for Hepatitis-C; Somavert for Acromegaly; PEG-INTRON for Hepatitis-C; Macugen for age-related macular degeneration; CIMZIA for Crohn's disease; MIRCERA for renal anemia and chronic kidney disease; CIMZIA for rheumatoid arthritis; Hematide, a Phase III product for Anemia; Macugen, a Phase II clinical trial product for diabetic macular edema and retinal vein occlusion; and CDP 791, a Phase II product for nonsmall cell lung cancer. In addition, Nektar's proprietary products include NKTR-102, a Phase II trial product for colorectal cancer; and NKTR-118, which is in Phase II clinical trials for opioid-induced constipation and other manifestations of opioid bowel dysfunction. The company was founded in 1990 and is headquartered in San Carlos, California.